IBS Symptoms, Triggers, and Treatment Options

Irritable bowel syndrome, commonly known as IBS, is one of the most prevalent gastrointestinal disorders worldwide, affecting an estimated 10 to 15 percent of the adult population. Despite its prevalence, IBS is widely misunderstood by both patients and the general public. Many people endure years of cramping, bloating, and unpredictable bowel habits before receiving a diagnosis, and even after diagnosis, navigating the landscape of dietary advice, medications, and conflicting information can feel overwhelming.

At InnoCre Health, we help patients in Maryland, Washington, and Delaware manage IBS through telehealth, providing symptom evaluation, personalized dietary guidance, medication management, and the diagnostic workup needed to rule out other conditions. This article will help you understand the different subtypes of IBS, identify your triggers, explore treatment options, and know when further testing is warranted.

Understanding IBS and Its Subtypes

IBS is a functional gastrointestinal disorder. This means it involves abnormal gut function without a detectable structural or biochemical problem on standard tests. The condition is marked by chronic or recurrent abdominal pain along with changes in bowel habits.

The Rome IV diagnostic criteria are the current standard for IBS diagnosis. Symptoms must include recurrent abdominal pain at least one day per week over the past three months, with onset at least six months earlier. The pain must be linked to two or more of the following: pain related to defecation, a change in stool frequency, or a change in stool form.

IBS is classified into subtypes based on the predominant stool pattern, and identifying your subtype is important because treatment strategies differ significantly.

IBS-C (Constipation-Predominant)

Patients with IBS-C experience hard or lumpy stools on at least 25 percent of bowel movements and loose or watery stools on less than 25 percent. Common symptoms include infrequent bowel movements, straining during defecation, a sensation of incomplete evacuation, and abdominal bloating that often worsens throughout the day. The abdominal pain in IBS-C may be somewhat relieved by a successful bowel movement.

IBS-D (Diarrhea-Predominant)

IBS-D is characterized by loose or watery stools on at least 25 percent of bowel movements and hard stools on less than 25 percent. Patients frequently experience urgency, which can be particularly distressing in social or work situations, along with cramping abdominal pain, excessive gas, and in some cases, fecal incontinence. Symptoms are often worse after meals, a response known as the exaggerated gastrocolic reflex.

IBS-M (Mixed) and IBS-U (Unsubtyped)

IBS-M involves significant alternation between constipation and diarrhea, with both hard and loose stools occurring frequently. IBS-U describes patients whose stool patterns do not clearly fit any of the other subtypes. Understanding that bowel patterns can fluctuate is important, as patients may shift between subtypes over time.

Common IBS Triggers

While the exact cause of IBS remains the subject of ongoing research, several factors are known to trigger or exacerbate symptoms. Identifying and managing personal triggers is one of the most effective components of IBS management.

Dietary Triggers and the FODMAP Approach

Food is one of the most significant and modifiable triggers for IBS symptoms. High-FODMAP foods are among the most commonly identified dietary culprits. FODMAP stands for Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols, which are short-chain carbohydrates that are poorly absorbed in the small intestine and rapidly fermented by gut bacteria, producing gas and drawing water into the intestine.

Common high-FODMAP foods include several groups. Wheat and rye products. Onions and garlic. Lactose-containing dairy products. Legumes and beans. Certain fruits such as apples, pears, and watermelon. Honey and high-fructose corn syrup. And sugar alcohols like sorbitol and mannitol, found in many sugar-free products.

The low-FODMAP diet is a structured, three-phase approach developed by researchers at Monash University. The elimination phase involves restricting high-FODMAP foods for two to six weeks to assess symptom improvement. The reintroduction phase systematically tests individual FODMAP groups to identify specific triggers. The personalization phase develops a long-term dietary plan that avoids only the FODMAPs that trigger symptoms while maintaining as varied a diet as possible. This protocol is most effective when guided by a healthcare provider or dietitian.

Stress and the Gut-Brain Axis

The relationship between stress and IBS is bidirectional. Stress and anxiety can trigger or worsen IBS symptoms through the gut-brain axis, a complex communication network between the central nervous system and the enteric nervous system of the gut. Conversely, living with unpredictable IBS symptoms can itself be a significant source of anxiety and stress, creating a cycle that can be difficult to break without targeted intervention.

Research has demonstrated that psychological therapies, including cognitive behavioral therapy and gut-directed hypnotherapy, are effective treatments for IBS, further supporting the central role of the gut-brain connection in this condition.

Other Common Triggers

Beyond diet and stress, several other factors can provoke IBS flares. These include hormonal fluctuations, which is why many women experience worsening symptoms around menstruation. Disrupted sleep patterns, sedentary behavior, certain medications including antibiotics and NSAIDs, and gastrointestinal infections can all trigger or exacerbate IBS symptoms. A subset of patients develop IBS following an acute episode of infectious gastroenteritis, a condition known as post-infectious IBS.

Treatment Options for IBS

Dietary Management

In addition to the low-FODMAP approach, several general dietary strategies can benefit IBS patients. Eating regular meals at consistent times, eating slowly and chewing thoroughly, staying well hydrated, and limiting caffeine, alcohol, and carbonated beverages can all help reduce symptom burden. Soluble fiber supplements such as psyllium may improve symptoms in IBS-C by softening stools and promoting regular bowel movements, though insoluble fiber such as wheat bran can sometimes worsen bloating and should be introduced cautiously.

Antispasmodic Medications

Antispasmodics are among the most commonly prescribed medications for IBS-related abdominal pain and cramping. These medications work by relaxing the smooth muscle of the intestinal wall, reducing painful contractions. Hyoscyamine and dicyclomine are frequently prescribed in the United States. They are often taken on an as-needed basis, 30 to 60 minutes before meals that typically trigger symptoms, or regularly during flare periods.

Peppermint oil capsules can be an effective non-prescription option. They are taken in enteric-coated form, so they dissolve in the intestines rather than the stomach. Multiple clinical trials have shown antispasmodic effects.

Medications for IBS-C

When dietary changes and fiber supplementation are insufficient for IBS-C, several prescription options are available. Linaclotide and plecanatide are guanylate cyclase-C agonists that increase fluid secretion into the intestines and accelerate transit. Lubiprostone is a chloride channel activator with a similar mechanism. These medications have been shown to improve both constipation and abdominal pain in IBS-C patients.

Osmotic laxatives such as polyethylene glycol can help with stool consistency, though they are not FDA-approved specifically for IBS-C and may not address the pain component of the condition as effectively as targeted IBS medications.

Medications for IBS-D

For IBS-D, loperamide is commonly used to reduce stool frequency and improve stool consistency, though it does not address abdominal pain. Eluxadoline is a mu-opioid receptor agonist approved specifically for IBS-D that can reduce both diarrhea and pain. Rifaximin, a non-absorbed antibiotic, has shown efficacy for IBS-D, particularly for bloating, and may work by modifying the gut microbiome. Bile acid sequestrants such as cholestyramine may benefit the subset of IBS-D patients with bile acid malabsorption.

Psychological and Integrative Approaches

Given the strong gut-brain connection in IBS, psychological therapies are an increasingly recognized component of comprehensive treatment. Cognitive behavioral therapy tailored to IBS has a strong evidence base and can help patients develop coping strategies, reduce symptom-related anxiety, and modify behaviors that may worsen symptoms. Gut-directed hypnotherapy, performed by trained therapists, has demonstrated significant symptom improvement in multiple randomized trials. Mindfulness-based stress reduction and regular physical exercise have also shown benefits for IBS symptom management.

When Further Testing Is Needed

IBS is a clinical diagnosis, meaning it is based on symptom criteria rather than a definitive diagnostic test. However, certain situations call for additional workup to rule out other conditions that can mimic IBS.

Baseline testing for IBS symptoms usually includes several lab studies. A complete blood count screens for anemia or infection. C-reactive protein or fecal calprotectin evaluates for inflammatory bowel disease. Tissue transglutaminase antibodies screen for celiac disease. Thyroid function tests are also helpful, since thyroid disorders can cause similar bowel symptoms.

If alarm symptoms are present, further evaluation such as colonoscopy, imaging, or referral to a gastroenterologist may be recommended. The presence of these features does not necessarily mean a serious condition is present, but they do warrant investigation to ensure an accurate diagnosis.

Managing IBS Through Telehealth

IBS is an excellent condition for telehealth management. The diagnosis is based on symptom history rather than physical examination, treatment adjustments often involve dietary counseling and medication changes, and ongoing management benefits from regular follow-up, all of which can be accomplished effectively through video visits.

At InnoCre Health, a telehealth visit for IBS with Atul S. Vellappally, DNP, CRNP, FNP-BC covers several things. We do a detailed symptom assessment and subtype classification. We discuss dietary strategies, including FODMAP guidance. We make medication recommendations tailored to your subtype and symptoms. We order appropriate diagnostic tests through local labs. And we plan follow-up to monitor your response to treatment. Visits are $68. We accept HSA and FSA payments. This provides accessible, evidence-based care without the barriers of traditional office visits.

Frequently Asked Questions